Your browser doesn't support javascript.
SARS-CoV-2-neutralizing antibody treatment in patients with COVID-19 and immunodeficiency due to B-cell non-Hodgkin lymphoma.
Malin, Jakob J; Di Cristanziano, Veronica; Horn, Carola; Pracht, Elisabeth; Garcia Borrega, Jorge; Heger, Eva; Knops, Elena; Kaiser, Rolf; Böll, Boris; Lehmann, Clara; Jung, Norma; Borchmann, Peter; Fätkenheuer, Gerd; Klein, Florian; Hallek, Michael; Rybniker, Jan.
  • Malin JJ; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Di Cristanziano V; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine, University of Cologne, Cologne, Germany.
  • Horn C; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; and.
  • Pracht E; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Garcia Borrega J; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Heger E; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Knops E; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; and.
  • Kaiser R; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; and.
  • Böll B; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
  • Lehmann C; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; and.
  • Jung N; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Borchmann P; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Fätkenheuer G; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
  • Klein F; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Hallek M; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Rybniker J; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Blood Adv ; 6(5): 1580-1584, 2022 03 08.
Article in English | MEDLINE | ID: covidwho-1574955
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / COVID-19 Topics: Long Covid Limits: Humans Language: English Journal: Blood Adv Year: 2022 Document Type: Article Affiliation country: Bloodadvances.2021006655

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / COVID-19 Topics: Long Covid Limits: Humans Language: English Journal: Blood Adv Year: 2022 Document Type: Article Affiliation country: Bloodadvances.2021006655